Medical/Pharmaceuticals
Medidata and the University of Sydney's NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia
Continuing collaboration will utilize the capabilities of the Medidata Data
Experience, fostering efficiency, fast-tracking research breakthroughs, and
raising the standard of clinical trials
SINGAPORE, July 10, 2025 /PRNewswire/ -- Medidata
LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico's Life Sciences Market
NORWALK, Conn., July 9, 2025 /PRNewswire/ -- LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, is pleased to announce the expansion of its distribution partnership with Clariant, a global leader in the development and manufacturing of specialty c...
NYSE Content advisory: Pre-Market update + Trump announces 50% levy on copper imports
NEW YORK, July 9, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content advisory: Pre-Market update + Trump announces 50% le...
IASO Bio Receives Orphan Drug Designation from the Ministry of Food and Drug Safety of South Korea for Equecabtagene Autoleucel
SHANGHAI, NANJING, China and SAN FRANCISCO, July 9, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies and biologics, today announced thatits self-developed an...
Sironax Grants Novartis Exclusive Option to Acquire its Brain Delivery Platform While Retaining Rights to Advance Selected Therapeutic Assets
WALTHAM, Mass., July 9, 2025 /PRNewswire/ -- Sironax, a clinical-stage biotech company dedicated to the discovery and development of transformational therapies for age-related diseases, today announced a strategic agreement with Novartis under which Sironax will grant Novartis an exclusive option...
Gozellix Receives Permanent HCPCS Code
MELBOURNE, Australia, July 9, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that its next-generation PSMA[1] PET[2] imaging agent, Gozellix® (kit for the preparation of gallium-68 (68Ga) gozetotide injection), has been granted a permanent Hea...
Watson-Marlow Fluid Technology Solutions focuses on BioClamp's sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025
TOKYO, July 9, 2025 /PRNewswire/ -- Visitors to the Watson-Marlow Fluid Technology Solutions booth W15-2 at INTERPHEX Tokyo 2025 (July 9-11 at Tokyo Big Sight, Japan) can learn more about the new WMArchitect Interchangeable Parts service as well as how recently advanced manufacturing of BioClamp ...
BiomeNrich™ PRO G814 & PRO G952: Globally Recognized Bifidobacterium Solutions Now Targeting Southeast Asia's Wellness Market
SEOUL, South Korea, July 9, 2025 /PRNewswire/ -- As Southeast Asia's health and wellness market rapidly evolves, consumer expectations are shifting toward multifunctional solutions that go beyond basic digestion. Gut health is now understood as the foundation for immune support, skin clarity, men...
Technimark Unveils New Brand Identity: "We Make What Makes Life Better"
ASHEBORO, N.C., July 9, 2025 /PRNewswire/ -- Technimark, a world leader in manufacturing for healthcare, consumer packaging, and industrial sectors, today launched a new brand identity to reflect the company's transformation into a global manufacturing leader, known for its reliability and excell...
Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
A recognized pioneer in metabolomics, Metabolon is the most experienced and trusted metabolomics partner in the life sciences industry MORRISVILLE, N.C., July 8, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science ...
GLOBAL NUTRACEUTICALS CAMPAIGN TO RAISE FUNDS FOR RESCUE SHELTER FOR CHILD SEXUAL ABUSE SURVIVORS
#HopeNeedsAHome Cypress Minerals and Cepham Inc lead Fundraising Efforts Because Hope Needs A Home - Deadline Looms As Mothers, Aged 11-17, Hope For Sanctuary they can call Home $140,000 USD needed by August 15 to Secure Home for young Mothers MADERA, Calif., July 8, 2025 /PRNewswire/ -- Tw...
3D-PRINTED CUSTOM INSOLES: ADVANCING DIABETIC FOOT CARE AT SENGKANG GENERAL HOSPITAL
SINGAPORE, July 8, 2025 /PRNewswire/ -- Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore General Hospital's (SGH) 3D printing centre. Traditional p...
Zuellig Pharma Launches "Obesity is a Disease" Seminar as Part of "Reduce Size, Reduce Disease" Campaign
The campaign aims to enhance the understanding of obesity as a chronic disease and solutions to help manage the disease among Thais and healthcare providers. BANGKOK, July 8, 2025 /PRNewswire/ -- Zuellig Pharma, a leading healthcare solutions provider inAsia, is organizing the "Obesity is a Disea...
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
SINGAPORE, July 8, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the Investigation...
Better by MTA Highlights Platinum Members Elevating Global Healthcare Standards
PALM BEACH GARDENS, Fla., July 8, 2025 /PRNewswire/ -- Better by MTA, the leading medical tourism platform, is proud to spotlight its distinguished Platinum Members—organizations that exemplify leadership, excellence, and innovation in the global medical travel industry. These members have played ...
Sirtex Medical's SIR-Spheres® Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the U.S. approved to treat both unresectable hepatocellular carcinoma and metastatic colorectal cancer WOBURN, Mass., July 7, 2025 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of intervent...
DoH, USCF and IGI Explore Establishing the World's first-of-their kind Centres for Genome Surgery
On the sidelines of a high-level U.S. visit ABU DHABI, UAE, July 4, 2025 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has announced a landmark partnership with the University of California, San Francisco (UCSF) and the Innovati...
Everest Medicines Showcases Breakthroughs in Proprietary AI-Powered mRNA Platform at 2025 R&D Day Held in Shanghai
SHANGHAI, July 4, 2025 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the "2025 Everest Medicines mRNA Platform R&D Day" in Shanghai. The e...
Kexing Biopharm Makes Its Debut at CPHI 2025, Followed by the 2025 International Pharmaceutical Cooperation High-End Forum, One of the Kexing Biopharm's Series of Globalization Activities in Shanghai
SHENZHEN, China, July 4, 2025 /PRNewswire/ -- Recently, Kexing Biopharm made a remarkable appearance at CPHI & PMEC China 2025 and successfully organized the 2025 International Pharmaceutical Cooperation High-End Forum, one of the Kexing Biopharm's series of globalization activities in Shanghai. ...
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
* Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China * Brii Biosciences retains ex-Greater China rights to address the global antimicrobial resistance threats and continues investment in other priority pipeline assets DURHAM, N.C. and BEIJING, J...
Week's Top Stories
Most Reposted
DBS is First Bank in Asia Pacific to Pilot Visa Intelligent Commerce for Everyday Payments
[Picked up by 322 media titles]
2026-02-16 10:00Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 321 media titles]
2026-02-19 14:30Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 280 media titles]
2026-02-17 19:12Kung Fu Meets Spring -- Unitree Spring Festival Gala Robots Present "Cyber Real Kung Fu" in the Year of the Horse
[Picked up by 259 media titles]
2026-02-17 14:16SMU MBA Rises in FT Global Rankings, Excelling in ESG, Salary and Value-for-Money
[Picked up by 253 media titles]
2026-02-16 08:00